These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

322 related items for PubMed ID: 11398905

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. Farnesyltransferase inhibitor effects on prostate tumor micro-environment and radiation survival.
    Shi Y, Wu J, Mick R, Cerniglia GJ, Cohen-Jonathan E, Rhim JS, Koch CJ, Bernhard EJ.
    Prostate; 2005 Jan 01; 62(1):69-82. PubMed ID: 15389805
    [Abstract] [Full Text] [Related]

  • 25. Recent advances in understanding the antineoplastic mechanisms of farnesyltransferase inhibitors.
    Pan J, Yeung SC.
    Cancer Res; 2005 Oct 15; 65(20):9109-12. PubMed ID: 16230362
    [Abstract] [Full Text] [Related]

  • 26. Inhibiting Ras signaling in the therapy of breast cancer.
    Li T, Sparano JA.
    Clin Breast Cancer; 2003 Feb 15; 3(6):405-16; discussion 417-20. PubMed ID: 12636885
    [Abstract] [Full Text] [Related]

  • 27. Farnesyltransferase inhibitors (FTIs) in myeloid malignancies.
    Karp JE, Lancet JE.
    Ann Hematol; 2004 Feb 15; 83 Suppl 1():S87-8. PubMed ID: 15124688
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Pre-clinical development of farnesyltransferase inhibitors.
    Lobell RB, Kohl NE.
    Cancer Metastasis Rev; 1998 Jun 15; 17(2):203-10. PubMed ID: 9770117
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Farnesyltransferase inhibitors induce DNA damage via reactive oxygen species in human cancer cells.
    Pan J, She M, Xu ZX, Sun L, Yeung SC.
    Cancer Res; 2005 May 01; 65(9):3671-81. PubMed ID: 15867362
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Synergistic cytotoxic effects in myeloid leukemia cells upon cotreatment with farnesyltransferase and geranylgeranyl transferase-I inhibitors.
    Morgan MA, Wegner J, Aydilek E, Ganser A, Reuter CW.
    Leukemia; 2003 Aug 01; 17(8):1508-20. PubMed ID: 12886237
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Farnesyltransferase inhibitors in breast cancer therapy.
    Dy GK, Adjei AA.
    Cancer Invest; 2002 Aug 01; 20 Suppl 2():30-7. PubMed ID: 12442347
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 17.